ISSN 1662-4009 (online)

ey0016.4-12 | New Paradigms | ESPEYB16

4.12. Expression of insulin-like growth factor I and its receptor in the liver of children with biopsy-proven NAFLD

A Alisi , V Pampanini , C De Stefanis , N Panera , A Deodati , V Nobili , S Cianfarani

To read the full abstract: PLoS One. 2018;13:e0201566.NAFLD is a multifactorial disease characterized by an abnormal accumulation of fat in the liver without a history of significant alcohol intake. NAFLD is the most common form of chronic liver disease, affecting 30% of adults and 10% of children in the USA [1]. Alarmingly, its prevalence is increasing worldwide paralleling to the incre...

ey0017.12-10 | Metabolic Syndrome | ESPEYB17

12.10. Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease

V Nobili , A Mantovani , S, et al. Cianfarani

To read the full abstract: J Hepatol. 2019;71(4):802–10. doi: 10.1016/j.jhep.2019.06.023Short summary: Prediabetes is highly prevalent in Caucasian children and adolescents with well-characterized, biopsy-proven non-alcoholic fatty liver disease (NAFLD).Comment: NAFLD is considered the liver presentation of the metabolic syndrome. NAFLD enco...

ey0017.4-14 | New paradigms | ESPEYB17

4.14. Circulating IGF-1 independently predicts blood pressure in children with higher calcium-phosphorus product levels

S Xargay-Torrent , E Dorado-Ceballos , A Benavides-Boixader , E Lizarraga-Mollinedo , B Mas-Pares , M Montesinos-Costa , F De Zegher , L Ibanez , J Bassols , A Lopez-Bermejo

To read the full abstract: J Clin Endocrinol Metab. 2020 Jan 1;105(1):dgz101.The aim of this prospective longitudinal study of 521 healthy children (8.8 ± 0.1) was to evaluate the correlation of circulating IGF-I levels with metabolic and cardiovascular parameters and the potential interaction with the Calcium-Phosphorus product (Ca*P). 158 subjects were re-evaluated after a follow-up of 5 years. Baseline IGF-I and IGF-I/IGFBP-3 molar r...